Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Emera $750 million fixed-to-fixed reset rate junior subordinated notes offering
We advised Emera on its offering
CytomX Therapeutics $250 million follow-on offering
We advised the representatives of the underwriters on the offering
Ormat Technologies $1 billion convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
Nestlé Capital $2 billion notes offering and concurrent tender offers
We advised the book-running managers on the offering and the dealer managers on the tender offer
Albemarle cash tender offers
We advised the dealer manager on the tender offers
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Versigent $1.6 billion senior notes offering
We advised Versigent on the offering, which is being made in conjunction with Aptiv’s planned spinoff of Versigent
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
PAR Technology $265 million convertible senior notes offering
We advised the representative of the initial purchasers on the offering
Amazon.com €14.5 billion notes offering
We advised the underwriters on the offering